Tenet Healthcare (NYSE:THC) CEO Sells 50,000 Shares

Key Points

• CEO Saumya Sutaria sold 50,000 Tenet Healthcare shares for approximately $13.94 million at an average price of $278.71, reducing her direct ownership by 9.37% to 483,564 shares.
• Tenet reported strong quarterly results, with EPS of $6.12 versus the $4.26 consensus estimate and revenue of $6.04 billion, up 6.8% year over year. The company guided to fiscal 2026 EPS of $20.30–$21.69.
• Analyst sentiment remains positive: 19 analysts rate the stock a Buy and one rates it a Hold, with a consensus price target of $273.00; institutional investors own 95.44% of the company.

Tenet Healthcare Corporation (NYSE:THC - Get Free Report) CEO Saumya Sutaria sold 50,000 shares of the business's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the sale, the chief executive officer directly owned 483,564 shares of the company's stock, valued at $134,774,122.44. This represents a 9.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Tenet Healthcare Price Performance

THC stock traded up $2.18 during trading on Wednesday, reaching $274.06. The company's stock had a trading volume of 513,308 shares, compared to its average volume of 844,938. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05. The company's fifty day moving average is $226.21 and its 200-day moving average is $208.66. The company has a market capitalization of $22.07 billion, a P/E ratio of 10.57, a price-to-earnings-growth ratio of 1.04 and a beta of 1.23.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion for the quarter, compared to analysts' expectations of $5.43 billion. During the same quarter in the previous year, the company earned $4.02 EPS. The business's quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts expect that Tenet Healthcare Corporation will post 20.98 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds have recently modified their holdings of the company. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare in the third quarter valued at about $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare during the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare during the fourth quarter worth $29,000. Meeder Asset Management Inc. increased its stake in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company's stock worth $38,000 after acquiring an additional 114 shares during the last quarter. Finally, Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $37,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

THC has been the topic of a number of recent research reports. TD Cowen increased their price objective on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a "buy" rating in a research note on Monday, July 27th. Zacks Research upgraded Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. Mizuho set a $290.00 price target on Tenet Healthcare in a report on Monday, August 10th. UBS Group upped their price objective on Tenet Healthcare from $288.00 to $308.00 and gave the stock a "buy" rating in a research note on Monday, July 27th. Finally, Raymond James Financial reaffirmed an "outperform" rating and set a $285.00 price objective on shares of Tenet Healthcare in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of "Buy" and a consensus price target of $273.00.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source